About AXOSIM, INC.
28bio is a neurotechnology company specializing in human brain organoids for neurotoxicity testing and CNS safety assessment. They use advanced 3D organoid models to predict clinical outcomes, particularly in seizure liability, with high sensitivity and specificity.
CNS toxicity testingPNS toxicity testingEfficacy assessmentNeuroinflammation researchAlzheimer’s disease modelingMyelination studiesCNS-3D Brain OrganoidsCNS-3D Inflammatory Organoids
Is this your company?
Claim AXOSIM, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim AXOSIM, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.